Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
about
Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor CellsNovel insights into the function and dynamics of extracellular matrix in liver fibrosis.Large-scale investigation of Leishmania interaction networks with host extracellular matrix by surface plasmon resonance imaging.Matricryptins and matrikines: biologically active fragments of the extracellular matrix.Effects of recombinant human endostatin on the expression of vascular endothelial growth factor in human gastric cancer cell line MGC-803.Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab.
P2860
Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
@en
Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
@nl
type
label
Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
@en
Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
@nl
prefLabel
Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
@en
Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
@nl
P2093
P2860
P356
P1476
Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
@en
P2093
Anthony Ambesi
David M Neskey
Paula J McKeown-Longo
P2860
P2888
P356
10.1186/1756-9966-27-61
P577
2008-11-04T00:00:00Z
P5875
P6179
1005638202